Search Results - "Hoeroldt, Barbara"

Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis by Dhaliwal, Harpreet K, Hoeroldt, Barbara S, Dube, Asha K, McFarlane, Elaine, Underwood, James C E, Karajeh, Mohammed A, Gleeson, Dermot

“…Biochemical remission is widely considered a satisfactory treatment end point in autoimmune hepatitis (AIH). The significance of persisting histological…”
Get full text

Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review by Al-Rifaie, Ammar, Khan, Mir Azam, Ali, Amjad, Dube, Asha Kumari, Gleeson, Dermot, Hoeroldt, Barbara

“…Lisinopril is an angiotensin converting enzyme inhibitor (ACE-I) that has been on market for more than 25 years. ACE-I are usually well tolerated and rarely…”
Get full text

Albumin level and patient age predict outcomes in patients referred for gastrostomy insertion: internal and external validation of a gastrostomy score and comparison with artificial neural networks by Leeds, John, MD, MBChB(Hons), MRCP, McAlindon, Mark E., MD, MBChB, FRCP, Grant, Julia, Robson, Helen E., BMedSci, Morley, Stephen R., MRCPath, James, Gary, FRCP, Hoeroldt, Barbara, MBChB, FRCP, Kapur, Kapil, MBChB, FRCP, Dear, Keith, MBChB, FRCP, Hensman, James, PhD, Worden, Keith, PhD, Sanders, David S., MD, MBChB, FRCP, FACG

“…Background Significant mortality after gastrostomy insertion remains and some risk factors have been identified, but no predictive scoring system exists…”
Get full text

H. pylori (HP) Serology: An Audit of Action on Positive Serology Results by Srinivas, M, James, Beth, Willemse, Pierre J, Basumani, Pandurangan, Hoeroldt, Barbara R, Bardhan, Karna D

Get full text

Fecal Calprotectin (FC) in Secondary Care: Unnecessary Hassle or Definite Help? by Srinivas, M, Eyre, R, Walsh, M, Basumani, Pandurangan, Hoeroldt, Barbara R, Willemse, Pierre J, Bardhan, Karna D

Get full text

THU-162-YI Lack of association between persistently raised serum transaminase levels and hepatic steatosis/steatohepatitis in autoimmune hepatitis (AIH) by Flatley, Sarah, Dube, Asha, Hoeroldt, Barbara, Harrison, Laura, Wadland, Elaine, Gleeson, Dermot

Get full text

WED-289 - Does fibrosis regression in autoimmune hepatitis require histological as well as biochemical remission? by Flatley, Sarah, Dube, Asha, Hoeroldt, Barbara, Harrison, Laura, Wadland, Elaine, Gleeson, Dermot

Get full text

Hepatic steatosis in patients with autoimmune hepatitis: relationship with corticosteroid treatment and long-term outcome by Flatley, Sarah, Dube, Asha, Gordon, Victoria, Hoeroldt, Barbara, Harrison, Laura, Wadland, Elaine, Gleeson, Dermot

Get full text

Does fibrosis regression in autoimmune hepatitis require histological as well as biochemical remission? by Flatley, Sarah, Dube, Asha, Hoeroldt, Barbara, Harrison, Laura, Wadland, Elaine, Gleeson, Dermot

Get full text

WED-273 - Hepatic steatosis in patients with autoimmune hepatitis: relationship with corticosteroid treatment and long-term outcome by Flatley, Sarah, Dube, Asha, Gordon, Victoria, Hoeroldt, Barbara, Harrison, Laura, Wadland, Elaine, Gleeson, Dermot

Get full text

Long-term Outcomes of Patients With Autoimmune Hepatitis Managed at a Nontransplant Center by Hoeroldt, Barbara, McFarlane, Elaine, Dube, Asha, Basumani, Pandurangan, Karajeh, Mohammed, Campbell, Michael J, Gleeson, Dermot

“…Background & Aims The long-term outcomes of patients treated for autoimmune hepatitis (AIH) are considered to be good. However, follow-up data beyond 10 years…”
Get full text

Long-term Outcome of Autoimmune Hepatitis: Consecutive Patient Cohort and Data on the Second Twenty Years by Harrison, Laura, Hoeroldt, Barbara, Dhaliwal, Harpreet, Wadland, Elaine, Dube, Asha, Gleeson, Dermot

“…Mortality rates for autoimmune hepatitis (AIH) vary. Data are lacking beyond 20 years follow-up. Analysis of a consecutively recruited large AIH cohort from a…”
Get full text

FRI-025-Long-term outcome in autoimmune hepatitis: The second twenty years by Harrison, Laura, Hoeroldt, Barbara, Mcfarlane, Elaine, Dube, Asha, Gleeson, Dermot

Get full text

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways by Cordell, Heather J., Han, Younghun, Mells, George F., Li, Yafang, Hirschfield, Gideon M., Greene, Casey S., Xie, Gang, Juran, Brian D., Zhu, Dakai, Qian, David C., Floyd, James A. B., Morley, Katherine I., Prati, Daniele, Lleo, Ana, Cusi, Daniele, Gershwin, M. Eric, Anderson, Carl A., Lazaridis, Konstantinos N., Invernizzi, Pietro, Seldin, Michael F., Sandford, Richard N., Amos, Christopher I., Siminovitch, Katherine A.

“…Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses…”
Get full text

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls by Murillo Perez, C. Fiorella, Fisher, Holly, Kareithi, Dorcas, Adekunle, Femi, Mayne, Tracy, Malecha, Elizabeth, van der Meer, Adriaan J., Lammers, Willem J., Battezzati, Pier Maria, Nevens, Frederik, Kowdley, Kris V., Cazzagon, Nora, Floreani, Annarosa, Parés, Albert, Londoño, Maria-Carlota, Carbone, Marco, Gatselis, Nikolaos K., Thorburn, Douglas, Verhelst, Xavier, Flack, Steve, Mulcahy, Victoria, Trauner, Michael, Corpechot, Christophe, Jones, David, Mells, George, Wason, James, Kallis, Yiannis, Wright, Gavin, Mathialahan, Thiriloganathan, Evans, Richard, Bhalme, Mahesh, Southern, Paul, Yousif, Mohamed, Mells, George, Foxton, Matthew, Collins, Carole, Prasad, Yash, Yapp, Tom, Patel, Minesh, Ede, Roland, Carte, Martyn, Sattianayagam, Prayman, Grimley, Charles, Mansour, Dina, Beckley, Matilda, Hollywood, Coral, Ramag, John, Gordon, Harriet, Ridpath, Joanne, Abouda, George, Rees, Ian, Banim, Paul, Sen, Sambit, Prasad, Geeta, Hutchinson, John, Gupta, Prakash, Jones, David, Saha, Subrata, Pollock, Katharine, Rushbrook, Simon, Przemioslo, Robert, Mitchell, Steven, Davis, Andrew, Naqvi, Asifabbas, Ryder, Stephen, Cramp, Matthew, Aspinal, Richard, Booth, Jonathan, Christie, John, Thorburn, Douglas, Ala, Aftab, Maltby, Julia, Corbett, Chris, Hoeroldt, Barbara, Butterworth, Jeff, Douglas, Andrew, Sinha, Rohit, Panter, Simon, Shearman, Jeremy, Bray, Gary, Forton, Daniel, Taylor, Nicola, Jafar, Wisam, Cowan, Matthew, Ch'ng, Chin Lye, Rahman, Mesbah, Wesley, Emma, Jain, Sanjiv, Mandal, Aditya, Gordon, Fiona, Unitt, Esther, Austin, Andrew, Vemala, Vishwaraj, Higham, Andrew, Fraser, Jocelyn, King, Alistair, Keld, Richard, Fellows, Helen, Gotto, James, Millson, Charles

“…The Primary Biliary Cholangitis (PBC) Obeticholic Acid (OCA) International Study of Efficacy (POISE) randomized, double-blind, placebo-controlled trial…”
Get full text

X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis by Cordell, Heather J., Jones, David E., Nakamura, Minoru, Liu, Xiangdong, Myers, Robert, Affronti, Andrea, Elia, Gianfranco, Colli, Agostino, Cazzagon, Nora, Rosina, Floriano, Malinverno, Federica, O’Donnell, Sarah E., Donato, Francesca, Fagiuoli, Stefano, Niro, Grazia A., Zuin, Massimo, Galli, Andrea, Yapp, Tom, Healey, Christopher, Czajkowski, Marek, Gyawali, Pranab, Premchand, Purushothaman, Watson, Alan, Subhani, Javaid, Prince, Martin, Elphick, David, Gooding, Ian, Austin, Andrew, Hovell, Christopher, Grimley, Charles, Broad, Andrea, Wood, Gordon, Wilkinson, Mark, Taylor-Robinson, Simon, Williams, Simon, Chilton, Andrew, Curtis, Howard, Aldersley, Mark, Srirajaskanthan, Raj, Sivaramakrishnan, Nurani, MacFaul, George, Jones, David, Campbell, Stewart, Macdonald, Christopher, Cramp, Matthew, Douds, Andrew, Patanwala, Imran, Brookes, Matthew, Mathew, Ray, Butcher, Graham, Sanghi, Pradeep, Gordon, Fiona, Unitt, Esther, Whalley, Simon, Wong, Voi Shim, Singhal, Amit, Gotto, James, Cloudsdale, Rebecca, Foale, Carole, Townshend, Paula, Sadeghian, Joy, Thomas, Carol, Wilkins, Joy, Ncube, Noma, Miller, Richard, Ducker, Samantha, Grieve, Emma, Walker, Kirsten, Jones, Linda, Marriott, Suzie, Tyrer, David, Lambourne, Victoria, Mills, Marisa, Taylor, Natalie, Hamilton, Maria, Gocher, Denise, Batham, Sally, Oblak, Metod, Baird, Yolanda, Cotterill, Donna, Greer, Sandra, Allison, Joanna, Nakamura, Hitomi, Komori, Atsumasa, Mannami, Tomohiko, Kouno, Hiroshi, Yamashita, Tsutomu, Tsunematsu, Seiji, Koda, Masaharu, Kobata, Tatsuro, Ohara, Yukio, Ishida, Jinya, Takikawa, Hajime, Ichikawa, Tatsuki, Sakisaka, Shotaro, Takeyama, Yasuaki, Shimoda, Shinji, Nakanuma, Yasuni, Soejima, Yuji, Cardamone, Giulia

“…Genome-wide association studies in primary biliary cholangitis (PBC) have failed to find X chromosome (chrX) variants associated with the disease. Here, we…”
Get full text

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score by Carbone, Marco, Nardi, Alessandra, Flack, Steve, Carpino, Guido, Varvaropoulou, Nikoletta, Gavrila, Caius, Spicer, Ann, Badrock, Jonathan, Bernuzzi, Francesca, Cardinale, Vincenzo, Ainsworth, Holly F, Heneghan, Michael A, Thorburn, Douglas, Bathgate, Andrew, Jones, Rebecca, Neuberger, James M, Battezzati, Pier Maria, Zuin, Massimo, Taylor-Robinson, Simon, Donato, Maria F, Kirby, John, Mitchell-Thain, Robert, Floreani, Annarosa, Sampaziotis, Fotios, Muratori, Luigi, Alvaro, Domenico, Marzioni, Marco, Miele, Luca, Marra, Fabio, Giannini, Edoardo, Gaudio, Eugenio, Ronca, Vincenzo, Bonato, Giulia, Cristoferi, Laura, Malinverno, Federica, Gerussi, Alessio, Stocken, Deborah D, Cordell, Heather J, Hirschfield, Gideon M, Alexander, Graeme J, Sandford, Richard N, Jones, David E, Invernizzi, Pietro, Mells, George F

“…Treatment guidelines recommend a stepwise approach to primary biliary cholangitis: all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy…”
Get more information

Gastrostomies Preserve But Do Not Increase Quality of Life for Patients and Caregivers by Kurien, Matthew, Andrews, Rebecca E, Tattersall, Rachel, McAlindon, Mark E, Wong, Emma F, Johnston, Alex J, Hoeroldt, Barbara, Dear, Keith L, Sanders, David S

“…Background & Aims Gastrostomies are widely used to provide long-term enteral nutrition to patients with neurologic conditions that affect swallowing (eg,…”
Get full text

Treatment and outcome of autoimmune hepatitis: Audit of 28 UK centres by Gordon, Victoria, Adhikary, Ratul, Appleby, Victoria, Das, Debasish, Day, James, Delahooke, Toby, Dixon, Selena, Elphick, David, Hardie, Claire, Heneghan, Michael A., Hoeroldt, Barbara, Hooper, Patricia, Hutchinson, John, Jones, Rebecca, Khan, Faisal, Aithal, Guruprasad P., Metcalf, Jane, Nkhoma, Alick, Pelitari, Stavroula, Prince, Martin, Prosser, Annell, Sathyanarayana, Vinay, Saksena, Sushma, Vani, Deven, Yeoman, Andrew, Abouda, George, Nelson, Andrew, Gleeson, Dermot, Healey, C., Sathyanarayana, V., Moreea, S., Verma, A., Alexander, G., Mells, G., Cacciottolo, T., Hall, E., Unitt, E., Atanze, S., Varyani, F., Ososanya, A., Horne, K., Sayer, J., Thayalasekaran, S., Savva, S., Shah, N., Watson, C., Lomas, Laura, Aldridge, J., Vani, D., Dyson, J., Metcalf, J., McGonigle, J., Mannion, L., Saraj, O., Das, D., Ch’ng, C., Millson, C.

“…Background With few data regarding treatment and outcome of patients with AIH outside of large centres we present such a study of patients with AIH in 28 UK…”
Get full text

Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UK by Gordon, Victoria, Adhikary, Ratul, Appleby, Victoria, Das, Debasis, Day, James, Delahooke, Toby, Dixon, Selena, Elphick, David, Hardie, Claire, Hoeroldt, Barbara, Hooper, Patricia, Hutchinson, John, Jones, Rebecca, Khan, Faisal, Aithal, Guruprasad P., McGonigle, John, Nelson, Andrew, Nkhoma, Alick, Pelitari, Stavroula, Prince, Martin, Prosser, Annell, Sathanarayana, Vinay, Savva, Sophia, Shah, Naina, Saksena, Sushma, Thayalasekaran, Sreedhari, Vani, Deven, Yeoman, Andrew, Gleeson, Dermot

“…Background & Aims There is limited information regarding patients with AIH outside relatively few large centres. We describe here the presenting features of…”
Get full text